CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. TOP PLAYER POSITIONING
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Increasing incidence of cancer and cardiovascular disorders
3.4.1.2. Increased research funding for miRNA

3.4.2. Restraints

3.4.2.1. Development of in-house tools reduces commercial consumption
3.4.2.2. Challenges in quantification of miRNA

3.4.3. Opportunities

3.4.3.1. Application of miRNA technology

3.4.3.1.1. miRNA biomarkers

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL miRNA TOOLS AND SERVICES MARKET, BY PRODUCTS AND SERVICES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. RESEARCH TOOLS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. SERVICES

4.3.1. Market size and forecast

4.3.1.1. miRNA extraction services

4.3.1.1.1. Market size and forecast

4.3.1.2. Quantification services

4.3.1.2.1. Market size and forecast

4.3.1.3. Microarray services

4.3.1.3.1. Market size and forecast

4.3.1.4. Sequencing services

4.3.1.4.1. Market size and forecast

4.3.1.5. Functional studies services

4.3.1.5.1. Market size and forecast

4.3.1.6. Other services

4.3.1.6.1. Market size and forecast

CHAPTER 5 GLOBAL miRNA TOOLS AND SERVICES MARKET, BY TECHNOLOGY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. QRT-PCR

5.2.1. Market size and forecast

5.3. NGS

5.3.1. Market size and forecast

5.4. MICROARRAY

5.4.1. Market size and forecast

5.5. FUNCTIONAL ANALYSIS TOOLS

5.5.1. Market size and forecast

5.6. miRNA EXTRACTION TOOLS

5.6.1. Market size and forecast

5.7. OTHERS

5.7.1. Market size and forecast

CHAPTER 6 GLOBAL miRNA TOOLS AND SERVICES MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. RESEARCH AND ACADEMIC INSTITUTES

6.2.1. Market size and forecast

6.3. IVD, PHARMA & BIOTECH COMPANIES

6.3.1. Market size and forecast

6.4. CRO

6.4.1. Market size and forecast

CHAPTER 7 GLOBAL miRNA TOOLS AND SERVICES MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Russia market size and forecast
7.3.10. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. Australia market size and forecast
7.4.7. India market size and forecast
7.4.8. South Korea market size and forecast
7.4.9. Taiwan market size and forecast
7.4.10. Indonesia market size and forecast
7.4.11. Thailand market size and forecast
7.4.12. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. Turkey market size and forecast
7.5.6. Venezuela market size and forecast
7.5.7. Saudi Arabia market size and forecast
7.5.8. Republic of South Africa market size and forecast
7.5.9. Colombia market size and forecast
7.5.10. Argentina market size and forecast
7.5.11. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. QIAGEN

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments, 2014-2016
8.1.6. Key strategy share, 2014-2016 (%)

8.2. THERMO FISHER SCIENTIFIC INC.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments, 2014-2016
8.2.6. Key strategy share, 2014-2016 (%)

8.3. ILLUMINA, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments, 2014-2016
8.3.6. Key strategy share, 2014-2016 (%)

8.4. AGILENT TECHNOLOGIES

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments, 2014-2016
8.4.6. Key strategy share, 2014-2016 (%)

8.5. GE HEALTHCARE DHARMACON INC.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments, 2014-2016
8.5.6. Key strategy share, 2014-2016 (%)

8.6. GENECOPOEIA, INC.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments, 2014-2016
8.6.6. Key strategy share, 2014-2016 (%)

8.7. PROMEGA CORPORATION

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Key strategic moves and developments, 2014-2016
8.7.5. Key strategy share, 2014-2016 (%)

8.8. BIO-RAD LABORATORIES, INC.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments, 2014-2016
8.8.6. Key strategy share, 2014-2016 (%)

8.9. MERCK & CO., INC.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments, 2014-2016
8.9.6. Key strategy share, 2014-2016 (%)

8.10. NEW ENGLAND BIOLABS

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Key strategic moves and developments, 2014-2016
8.10.5. Key strategy share, 2014-2016 (%)